No Data
JCR Pharmaceuticals Launches Key JR-142 Clinical Trial
Stocks that moved the day before part 2: Osaka Chemical Industry, Liberta, Terra Drone, ETC.
Stock Name <Code> Closing Price on 17th ⇒ Change from Previous Day SHIFT <3697> 16,970 -705 JP Morgan Securities has downgraded its investment rating. Sakura Internet <3778> 4,260 -265 fell below the 4,500 yen level. Double Scope <6619> 266 -6 experienced a dominant trend of short-term investor sell-offs due to sluggish movements. Monex Group <8698> 1,016 -48 saw a dominant trend of sell-offs from short-term investors after falling below the 25-day moving average. JCR Pharma <4
List of cloud break stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud break stocks]
○ List of stocks that broke below the cloud market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1332> Nissui 907 921.5 918.5 <1375> Yukiguni Maitake 1013 1030.25 1019.5 <1860> Toda Corporation 9219 27.25 957 <1882> Toa Road 1291 1304 1340.5 <1893> Goyo Construction 621 632.75 624 <196
December 4th [Today's Investment Strategy]
[FISCO Selected Stocks] [Material Stocks] JCR Pharma <4552> 727 yen (12/3) Human growth hormone preparations are the main products. Regarding the blood-brain barrier crossing type α-N-acetylglucosaminidase preparation (JR-446) developed by the company, the first administration to the first subject targeted at mucopolysaccharidosis type 3B (MPS3B) in clinical phase 1/2 trials in Japan was announced. MPS3B is being jointly developed and commercialized with Medipal Holdings <7459>.
Pay attention to JCR Pharma and ABC Mart, while Uchida Yoko and Tsukishima HD may be sluggish.
In the U.S. stock market on the 3rd of yesterday, the dow jones industrial average decreased by 76.47 dollars, closing at 44,705.53, the nasdaq rose by 76.96 points to 19,480.91, and the Chicago Nikkei 225 futures increased by 90 yen compared to during the day in Osaka, reaching 39,240 yen. The exchange rate is 1 dollar = 149.50-150.00 yen. In today's Tokyo market, the same-store sales for November increased by 14.7%, expanding from the 6.3% growth in October for ABC Mart <2670>, and the same-store sales for November rose by 8.9%, compared to the 6.3% in October.
JCR Pharmaceuticals Initiates Clinical Trial for MPS IIIB